| Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 (NCT05034874) | InterveXion Therapeutics, LLC | 2022-06-09 |
| Demonstration of a Digital Care Program for Methamphetamine Use Disorder (NCT05206175) | Affect Therapeutics, Inc. | 2022-02-14 |
| rTMS for Stimulant Use Disorders (NCT04907357) | Medical University of South Carolina | 2022-02-04 |
| Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics (NCT04706624) | Hanoi Medical University | 2021-06-29 |
| FASTLANE II: Reducing Sex, Drug, and Mental Health Risk (NCT04109014) | University of Southern California | 2021-05-03 |
| Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder (NCT05266716) | Affect Therapeutics, Inc. | 2021-02-18 |
| Delivering Contingency Management in Outpatient Addiction Treatment (NCT04544124) | University of Calgary | 2021-01-25 |
| Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder (NCT05550493) | Adai Technology (Beijing) Co., Ltd. | 2021-01-01 |
| Cardiovascular Effects of Prenatal Methamphetamine Exposure (NCT04616625) | University of California, Davis | 2020-10-05 |
| A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorders (NCT04883021) | University of New Mexico | 2020-08-01 |
| Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse (NCT04264741) | Shanghai Mental Health Center | 2020-02-01 |
| Screening of Pulmonary Hypertension in Methamphetamine Abusers (NCT04019600) | The University of Hong Kong | 2019-12-23 |
| Change in Cognitive Function in Stimulant Users (NCT04061941) | The University of Hong Kong | 2019-10-21 |
| Exercise in Methamphetamine Use Disorder Upregulation and Neural Function (NCT03709667) | University of California, Los Angeles | 2019-06-26 |
| Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use (NCT03864653) | Friends Research Institute, Inc. | 2019-02-25 |
| The Getting Off App for Methamphetamine-Using Gay and Bisexual Men (NCT03884946) | Friends Research Institute, Inc. | 2019-01-30 |
| Amphetamine Induced Adult Respiratory Distress Syndrome (NCT05611385) | Arrowhead Regional Medical Center | 2019-01-01 |
| Stimulant Use and Methylation in HIV (NCT05916989) | Florida International University | 2018-09-30 |
| Study of Antibody for Methamphetamine Outpatient Therapy (NCT03336866) | InterveXion Therapeutics, LLC | 2018-05-03 |
| rTMS for Craving in Methamphetamine Use Disorder (NCT03470480) | Oregon Health and Science University | 2018-02-07 |
| Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users (NCT03059563) | University of California, Los Angeles | 2018-01-11 |
| Pharmacogenetics of Naltrexone for Stimulant Abuse (NCT03226223) | New York State Psychiatric Institute | 2016-09-15 |
| Contingency Management for Meth in South Africa Methamphetamine Abuse in South Africa (NCT02907853) | University of California, Los Angeles | 2015-09-01 |
| Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse (NCT01967381) | University of Kentucky | 2013-10-01 |
| Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade (NCT01822132) | Oregon Health and Science University | 2013-05-01 |
| Buspirone as a Candidate Medication for Methamphetamine Abuse (NCT01843205) | University of Kentucky | 2013-04-01 |
| Safety Study of Ch-mAb7F9 for Methamphetamine Abuse (NCT01603147) | InterveXion Therapeutics, LLC | 2012-04-01 |
| Varenicline for Methamphetamine Dependence (NCT01365819) | University of California, Los Angeles | 2012-02-01 |
| Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence (NCT01273701) | National Taiwan University Hospital | 2011-01-01 |
| NAC as a Potential Treatment for Methamphetamine Dependence (NCT01063205) | Baylor College of Medicine | 2010-03-01 |
| RTI-336 as a Treatment for Methamphetamine Dependence (NCT01601717) | Baylor College of Medicine | 2010-01-01 |
| Safety Assessment of Atomoxetine With MA IV Administration (NCT01019707) | University of California, Los Angeles | 2009-10-01 |
| Rivastigmine as a Treatment for Methamphetamine Dependence (NCT01073319) | Baylor College of Medicine | 2009-07-01 |
| An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence (NCT01062451) | Baylor College of Medicine | 2009-05-01 |
| Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) (NCT00603434) | University of Cincinnati | 2008-01-01 |
| Varenicline-Methamphetamine Interaction Study (2008) (NCT00733967) | Baylor College of Medicine | 2008-01-01 |
| Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine (NCT00291512) | University of California, San Diego | |